Mast Cell Degranulating (MCD) Peptide
CAS No. 83856-13-7
Mast Cell Degranulating (MCD) Peptide( ——— )
Catalog No. M41898 CAS No. 83856-13-7
Mast Cell Degranulating (MCD) Peptide
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMast Cell Degranulating (MCD) Peptide
-
NoteResearch use only, not for human use.
-
Brief DescriptionMast Cell Degranulating (MCD) Peptide
-
DescriptionMast Cell Degranulating (MCD) Peptide
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number83856-13-7
-
Formula Weight2583.27
-
Molecular FormulaC110H188N40O24S4
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Aurantio-obtusin
Aurantio-obtusin is a promising osteoanabolic compound of natural origin with potential therapeutic applications in the prevention of osteoporosis and other metabolic bone diseases.
-
3-Hydroxybenzaldehyd...
3-Hydroxybenzaldehyde is a compound useful in organic synthesis.
-
3-(3-Hydroxyphenyl)p...
3-(3-Hydroxyphenyl)propionic Acid is one of the major metabolites of ingested caffeic acid.it?inhibited osteoclastogenesis and bone osteoclastic resorptive activity.
Cart
sales@molnova.com